FDA Plans New Board To Monitor Drug Safety

The Food and Drug Administration will create an independent board to more aggressively monitor the safety of drugs on the market as part of an effort to restore public confidence in the nation’s prescription drug supply, Health and Human Services Secretary Mike Leavitt announced yesterday.


Leave a Reply

Your email address will not be published. Required fields are marked *

Get email updates

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Subscribe!